Repare Therapeutics Inc (RPTX)
3.25
-0.01
(-0.31%)
USD |
NASDAQ |
Nov 14, 16:00
3.24
-0.01
(-0.31%)
After-Hours: 20:00
Repare Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.073M |
| March 31, 2024 | 52.40M |
| December 31, 2023 | 13.05M |
| September 30, 2023 | 2.159M |
| June 30, 2023 | 30.25M |
| March 31, 2023 | 5.678M |
| December 31, 2022 | 18.20M |
| September 30, 2022 | 112.54M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.679M |
| March 31, 2022 | 0.408M |
| December 31, 2021 | 6.877M |
| September 30, 2021 | 0.278M |
| June 30, 2021 | 0.279M |
| March 31, 2021 | 0.166M |
| December 31, 2020 | 0.135M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.135M
Minimum
Dec 2020
112.54M
Maximum
Sep 2022
16.28M
Average
2.159M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 67.77M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.084M |
| InMed Pharmaceuticals Inc | 1.283M |
| Xenon Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.41M |
| Total Expenses (Quarterly) | 34.84M |
| EPS Diluted (Quarterly) | -0.81 |
| Enterprise Value | -40.00M |
| Earnings Yield | -61.73% |
| Normalized Earnings Yield | -50.61 |